Sean Parker’s cancer institute may have found a blood test to find out if patients will respond to treatment

 Scientists in collaboration with tech billionaire Sean Parker’s Institute for Cancer Immunotherapy may have found a way to predict whether melanoma patients will respond to treatments that target the PD-1 (programmed cell death protein) pathway in tumors through a simple blood test, according to a paper in the scientific journal Nature. The former Facebook president launched the… Read More

from TechCrunch